Table 3 Antibiotic susceptibility pattern of bacterial isolates
Organisms | Antibiotics Used | Susceptibility Patterns | Resistant | |
|---|---|---|---|---|
Susceptible | Intermediate | |||
Streptococcus pneumoniae (N = 14) | Azithromycin | 14 | 0 | 0 |
Ceftazidime | 14 | 0 | 0 | |
Chloramphenicol | 14 | 0 | 0 | |
Ciprofloxacin | 14 | 0 | 0 | |
Moxifloxacin | 14 | 0 | 0 | |
Ofloxacin | 14 | 0 | 0 | |
Viridians group of streptococci (N = 3) | Azithromycin | 3 | 0 | 0 |
Ceftazidime | 3 | 0 | 0 | |
Chloramphenicol | 3 | 0 | 0 | |
Ciprofloxacin | 3 | 0 | 0 | |
Moxifloxacin | 3 | 0 | 0 | |
Ofloxacin | 3 | 0 | 0 | |
Staphylococcus aureus (N = 1) | Amikacin | 1 | 0 | 0 |
Ceftazidime | 1 | 0 | 0 | |
Chloramphenicol | 0 | 0 | 1 | |
Ciprofloxacin | 0 | 1 | 0 | |
Moxifloxacin | 1 | 0 | 0 | |
Ofloxacin | 1 | 0 | 0 | |
Bacillus species (N = 3) | Amikacin | 3 | 0 | 0 |
Azithromycin | 1 | 0 | 2 | |
Chloramphenicol | 1 | 0 | 2 | |
Ciprofloxacin | 3 | 0 | 0 | |
Moxifloxacin | 3 | 0 | 0 | |
Ofloxacin | 3 | 0 | 0 | |
Nocardia species (N = 3) | Amikacin | 3 | 0 | 0 |
Azithromycin | 1 | 0 | 2 | |
Chloramphenicol | 3 | 0 | 0 | |
Ciprofloxacin | 1 | 0 | 2 | |
Moxifloxacin | 3 | 0 | 0 | |
Ofloxacin | 1 | 0 | 2 | |
Pseudomonas aeruginosa (N = 1) | Amikacin | 1 | 0 | 0 |
Ceftazidime | 0 | 0 | 1 | |
Chloramphenicol | 0 | 0 | 1 | |
Ciprofloxacin | 1 | 0 | 0 | |
Moxifloxacin | 1 | 0 | 0 | |
Ofloxacin | 1 | 0 | 0 | |